Financhill
Back

Cullinan Therapeutics Quote, Financials, Valuation and Earnings

Cullinan Therapeutics Price Quote

$11.76
+0.01 (+-3.61%)
(Updated: December 14, 2024 at 3:51 AM ET)

Cullinan Therapeutics Key Stats

Sell
29
Cullinan Therapeutics (CGEM) is a Sell

Day range:
$11.58 - $12.17
52-week range:
$8.02 - $30.19
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.09%

Volume:
369.4K
Avg. volume:
566.2K
1-year change:
38.56%
Market cap:
$684.2M
Revenue:
$0
EPS:
$-2.84

How Much Does Cullinan Therapeutics Make?

Data Unavailable

Is Cullinan Therapeutics Growing As A Company?

Data Unavailable

Cullinan Therapeutics Stock Price Performance

What Is Cullinan Therapeutics 52-Week High & Low?

Cullinan Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cullinan Therapeutics?

Is Cullinan Therapeutics Cash Flow Positive?

  • What Is CGEM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$126.8M
  • What Is Cullinan Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $264.9M
  • What Is Cullinan Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$100.8M

Cullinan Therapeutics Return On Invested Capital

Data Unavailable

Cullinan Therapeutics Earnings Date & Stock Price

Cullinan Therapeutics Competitors

Cullinan Therapeutics Dividend Yield

Cullinan Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 10.29%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 33.00
Upside from Last Price: 180.85%

Major Shareholders

  • How many CGEM shares are owned by institutional investors?
    87.3M CGEM shares are owned by institutional investors
  • How many CGEM shares are owned by insiders?
    2.7M CGEM shares are owned by insiders